肝切除术后风险评分可识别90天死亡高危患者
该研究基于德国海德堡大学1796例肝切除超过一个肝段患者的资料,建立了预测90天院内死亡的术前风险评分,并在卡尔斯鲁厄281例患者中完成外部验证。评分将患者分为极低危(0-1分,死亡率0.2%)、低危(2-3分,2.9%)、中危(4-5分,14.7%)和高危(≥6分,33%)四组,C指数分别为0.86和0.89,可用于术前识别高危患者。
要点
- 风险评分基于年龄、ASA分级、肿瘤类型、INR、γ-GT、血小板、肌酐及右三肝切除等变量。
- 评分将患者分为四组,高危组90天死亡率达33%。
- 外部验证C指数0.89,提示评分区分度良好。
核心结论
- 基于患者相关因素和手术特异性变量构建的术前风险评分,可用于识别肝切除术后90天死亡高危患者。
研究设计与样本
- 回顾性分析德国海德堡大学1796例肝切除超过一个肝段患者的记录,主要终点为90天院内死亡,采用多因素logistic回归筛选风险因素并构建评分。
- 外部验证使用德国卡尔斯鲁厄281例患者的资料。
主要发现
- 总体并发症率(Clavien-Dindo II级及以上)为32%,30天和90天死亡率分别为3.0%和4.5%。
- 多因素分析中与90天院内死亡独立相关的因素包括:年龄≥60岁(OR 3.71)、ASA III级(OR 2.94)、ASA IV级(OR 15.66)、肝门部胆管癌(OR 5.65)、肝内胆管癌(OR 3.08)、INR≥1.1(OR 2.43)、γ-GT≥60 U/L(OR 2.86)、血小板≤120/nL(OR 5.52)、肌酐≥2 mg/dL(OR 9.85)及右三肝切除(OR 2.88)。
- 风险评分将患者分为极低危(0-1分,662例,死亡率0.2%)、低危(2-3分,769例,2.9%)、中危(4-5分,232例,14.7%)和高危(≥6分,57例,33%)四组(P < .0001)。
- 评分预测90天死亡的C指数为0.86,外部验证C指数为0.89(P = .0002)。
临床怎么用
- 术前可使用该评分对拟行肝切除患者进行风险分层,识别高危患者以辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, the profile for patients undergoing complex liver resections has changed, with mortality rates remaining generally stable. With these factors in mind, the objective of this study was to evaluate the variables associated with surgical outcomes after hepatectomy and identify groups at high risk for postoperative mortality. METHODS: The records of 1,796 patients who underwent liver resection of more than one liver segment at the Department of General and Transplantation Surgery, University Hospital Heidelberg, Germany, were analyzed. The primary end point was a 90-day in-hospital mortality. Logistic regression analyses were performed to identify risk factors associated with mortality. A risk score was created in accordance with weighted points based on the odds ratios obtained from multivariate logistic regression analyses. External validation of the score was performed, using data derived from 281 patients at the board-certified center for liver surgery in Karlsruhe, Germany. RESULTS: The overall patient morbidity rate (Clavien-Dindo Grade II or greater) was 32%. The 30- and 90-day mortality rates were 3.0% and 4.5%, respectively. In multivariate analysis, factors independently associated with risk for 90-day in-hospital mortality were age ≥60 years (OR 3.71), ASA classification III (OR 2.94), ASA IV (15.66), perihilar cholangiocarcinoma (OR 5.65), intrahepatic cholangiocarcinoma (OR 3.08), INR ≥ 1.1 (OR 2.43), g-GT ≥ 60 U/L (OR 2.86), platelet count ≤ 120/nL (OR 5.52), creatinine ≥ 2 mg/dL (OR 9.85), and right trisectionectomy (OR 2.88). The 90-day mortality-risk score that was created based on these factors effectively stratified patients into very low risk (0-1 points, 0.2% mortality rate in 662 patients), low risk (2-3 points, 2.9% mortality rate in 769 patients), medium risk (4-5 points, 14.7% mortality rate in 232 patients), and high risk (≥6 points, 33% mortality rate in 57 patients) groups (P < .0001). As a performance metric, the C-index for the proposed risk score for 90-day mortality was 0.86; whereas external validation revealed that this C-index was 0.89 (P = .0002). CONCLUSION: Based on patient-related factors and procedure-specific variables, the proposed preoperative-risk score can be used to identify high-risk patients to determine 90-day mortality after liver resection.
引用
- Hoffmann K, Hinz U, Stravodimos C, et al. Risk assessment for liver resection. Surgery. 2018. PMID: 30107885. doi:10.1016/j.surg.2018.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。